FMP
Amarin Corporation plc
AMRN
NASDAQ
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
0.457 USD
0.0131 (2.87%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Aaron D. Berg
sector
Healthcare
industry
Biotechnology
website
https://www.amarincorp.comexchange
NASDAQ
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the...
CIK
0000897448
ISIN
US0231112063
CUSIP
023111206
Address
Grand Canal Docklands
Phone
353 1 669 9020
Country
IE
Employee
275
IPO Date
Apr 1, 1993
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
AMRN Financial Summary
CIK
0000897448
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
023111206
ISIN
US0231112063
Country
IE
Price
0.46
Beta
1.93
Volume Avg.
1.29M
Market Cap
187.82M
Shares
-
52-Week
0.43-1.37
DCF
-0.23
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-4.57
P/B
-
Website
https://www.amarincorp.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest AMRN News
It looks like there's no news available.
